Digitalizing Across mAbs, Bispecifics, ADCs
Japan: JBA "NGS for CQA Assessment of Biological Products"
Process Changes Impacting AAV CQAs Assessed with NGS
NGS as MAM to Support AAV Gene Therapy Production
Automating Peptide Mapping Data Analysis Workflows
Now is the Time for MS Screening Labs to Scale Up Projects
ScRNA-seq for Cell Line Heterogeneity Assessment
Comprehensive Biosafety for Viral Vector Vaccines
What’s New in Genedata Screener 20
Advancing a Prognostic Biomarker Panel for Pediatric Crohn’s Disease
Unlocking Translational Insights from Tempus Real-World Data
Automation of Biosafety and Critical Quality Attribute Assessment
Evaluating Random Transgene Integration Using NGS
MS-Based Characterization of N- and O-Linked Glycosylation Sites
Automating Image Analysis with Deep Learning
Accelerated mAb Manufacturing 3 Months to GMP
Japan: Benefits of Expressionist Workflows in MS Data Analysis
What's New in Screener 19 and Imagence 5
Newly Discovered miRNA Impacts CHO Monoclonal Antibodies
High-Throughput Intact Mass Analysis Using Parameterization
Automating MS-Based Biotherapeutic Characterization
Identification of IgG2 Disulfide Isoforms
HT MS-based Characterization of Multispecifics at Sanofi
Analyzing Phenotypic Screening Data With Genedata Screener
Enhancing the Integration of Translational Datasets
Mass Spec-Based Analysis of Emerging Biotherapeutics
Automated Analysis of Complex Biphasic PROTAC Dose Response Data
What's New in Genedata Screener 18
Running Automated Assay Cascades in the Digital Lab
Cell Line Characterization 2.0
Genedata Imagence 3.0 Is Here! See What's New.
AI-powered HCS Analytics with Genedata Imagence 3.0
Flow Cytometry, Automated Analysis and Reporting
Automated Monitoring of Glycosylation in Biopharmaceuticals
Streamlining the Analysis of Compound Combination Screens
Interpretation of Mechanistic Screening Data
Protein Engineering: Bi- and Multi-Specifics, TCRs, and CAR Ts
Merging Automation and Data Management Technology
Integrating Automated and Manual Cell Line Development Workflows
MAM Validation in Biopharma Process Characterization
